nodes	percent_of_prediction	percent_of_DWPC	metapath
Mivacurium—BCHE—Irinotecan—stomach cancer	0.129	1	CbGbCtD
Mivacurium—BCHE—diaphragm—stomach cancer	0.0871	0.254	CbGeAlD
Mivacurium—CHRM3—muscle of abdomen—stomach cancer	0.0856	0.249	CbGeAlD
Mivacurium—CHRNA1—hematopoietic system—stomach cancer	0.0276	0.0806	CbGeAlD
Mivacurium—Hypoxemia—Methotrexate—stomach cancer	0.0252	0.0557	CcSEcCtD
Mivacurium—Injection site reaction—Mitomycin—stomach cancer	0.0232	0.0513	CcSEcCtD
Mivacurium—CHRNA1—lymphoid tissue—stomach cancer	0.0195	0.0567	CbGeAlD
Mivacurium—CHRNA1—endocrine gland—stomach cancer	0.0159	0.0463	CbGeAlD
Mivacurium—CHRNA2—endocrine gland—stomach cancer	0.0132	0.0384	CbGeAlD
Mivacurium—Erythema—Floxuridine—stomach cancer	0.013	0.0288	CcSEcCtD
Mivacurium—Muscle spasms—Floxuridine—stomach cancer	0.0125	0.0277	CcSEcCtD
Mivacurium—CHRNB1—liver—stomach cancer	0.0111	0.0322	CbGeAlD
Mivacurium—Anaphylactic shock—Floxuridine—stomach cancer	0.0106	0.0235	CcSEcCtD
Mivacurium—Erythema—Mitomycin—stomach cancer	0.0102	0.0226	CcSEcCtD
Mivacurium—CHRM3—smooth muscle tissue—stomach cancer	0.00982	0.0286	CbGeAlD
Mivacurium—BCHE—hematopoietic system—stomach cancer	0.0091	0.0265	CbGeAlD
Mivacurium—CHRNB1—lymph node—stomach cancer	0.00848	0.0247	CbGeAlD
Mivacurium—BCHE—smooth muscle tissue—stomach cancer	0.00801	0.0234	CbGeAlD
Mivacurium—Hypoxia—Methotrexate—stomach cancer	0.00796	0.0176	CcSEcCtD
Mivacurium—CHRM2—endocrine gland—stomach cancer	0.00786	0.0229	CbGeAlD
Mivacurium—CHRM3—digestive system—stomach cancer	0.00775	0.0226	CbGeAlD
Mivacurium—Anaphylactoid reaction—Irinotecan—stomach cancer	0.00761	0.0168	CcSEcCtD
Mivacurium—Injection site reaction—Docetaxel—stomach cancer	0.00697	0.0154	CcSEcCtD
Mivacurium—Injection site reaction—Capecitabine—stomach cancer	0.00675	0.0149	CcSEcCtD
Mivacurium—Rash—Floxuridine—stomach cancer	0.0067	0.0148	CcSEcCtD
Mivacurium—Dermatitis—Floxuridine—stomach cancer	0.00669	0.0148	CcSEcCtD
Mivacurium—CHRM3—endocrine gland—stomach cancer	0.0064	0.0187	CbGeAlD
Mivacurium—BCHE—digestive system—stomach cancer	0.00633	0.0184	CbGeAlD
Mivacurium—Phlebitis—Docetaxel—stomach cancer	0.00591	0.0131	CcSEcCtD
Mivacurium—BCHE—bone marrow—stomach cancer	0.00583	0.017	CbGeAlD
Mivacurium—Phlebitis—Capecitabine—stomach cancer	0.00572	0.0126	CcSEcCtD
Mivacurium—Dizziness—Mitomycin—stomach cancer	0.00551	0.0122	CcSEcCtD
Mivacurium—Rash—Mitomycin—stomach cancer	0.00526	0.0116	CcSEcCtD
Mivacurium—Dermatitis—Mitomycin—stomach cancer	0.00525	0.0116	CcSEcCtD
Mivacurium—BCHE—endocrine gland—stomach cancer	0.00523	0.0152	CbGeAlD
Mivacurium—Bradycardia—Irinotecan—stomach cancer	0.00519	0.0115	CcSEcCtD
Mivacurium—Cardiac disorder—Irinotecan—stomach cancer	0.00473	0.0105	CcSEcCtD
Mivacurium—Flushing—Irinotecan—stomach cancer	0.00473	0.0105	CcSEcCtD
Mivacurium—BCHE—liver—stomach cancer	0.00471	0.0137	CbGeAlD
Mivacurium—Injection site reaction—Epirubicin—stomach cancer	0.0047	0.0104	CcSEcCtD
Mivacurium—Angiopathy—Irinotecan—stomach cancer	0.00462	0.0102	CcSEcCtD
Mivacurium—Immune system disorder—Irinotecan—stomach cancer	0.0046	0.0102	CcSEcCtD
Mivacurium—Mediastinal disorder—Irinotecan—stomach cancer	0.00459	0.0102	CcSEcCtD
Mivacurium—Arrhythmia—Irinotecan—stomach cancer	0.00455	0.0101	CcSEcCtD
Mivacurium—Arrhythmia—Fluorouracil—stomach cancer	0.00436	0.00964	CcSEcCtD
Mivacurium—Injection site reaction—Doxorubicin—stomach cancer	0.00435	0.00962	CcSEcCtD
Mivacurium—Bronchospasm—Docetaxel—stomach cancer	0.00433	0.00957	CcSEcCtD
Mivacurium—Muscle spasms—Irinotecan—stomach cancer	0.00427	0.00943	CcSEcCtD
Mivacurium—Erythema—Fluorouracil—stomach cancer	0.00425	0.00939	CcSEcCtD
Mivacurium—Bronchospasm—Capecitabine—stomach cancer	0.00419	0.00926	CcSEcCtD
Mivacurium—Phlebitis—Epirubicin—stomach cancer	0.00399	0.00881	CcSEcCtD
Mivacurium—Anaphylactoid reaction—Methotrexate—stomach cancer	0.00379	0.00838	CcSEcCtD
Mivacurium—Phlebitis—Doxorubicin—stomach cancer	0.00369	0.00815	CcSEcCtD
Mivacurium—Anaphylactic shock—Irinotecan—stomach cancer	0.00362	0.008	CcSEcCtD
Mivacurium—BCHE—lymph node—stomach cancer	0.00361	0.0105	CbGeAlD
Mivacurium—Anaphylactoid reaction—Epirubicin—stomach cancer	0.00355	0.00784	CcSEcCtD
Mivacurium—Bradycardia—Capecitabine—stomach cancer	0.00347	0.00767	CcSEcCtD
Mivacurium—Anaphylactic shock—Fluorouracil—stomach cancer	0.00347	0.00766	CcSEcCtD
Mivacurium—Tachycardia—Fluorouracil—stomach cancer	0.00338	0.00748	CcSEcCtD
Mivacurium—Hypotension—Irinotecan—stomach cancer	0.00338	0.00748	CcSEcCtD
Mivacurium—Anaphylactoid reaction—Doxorubicin—stomach cancer	0.00328	0.00726	CcSEcCtD
Mivacurium—Flushing—Docetaxel—stomach cancer	0.00327	0.00723	CcSEcCtD
Mivacurium—Cardiac disorder—Docetaxel—stomach cancer	0.00327	0.00723	CcSEcCtD
Mivacurium—Hypotension—Fluorouracil—stomach cancer	0.00324	0.00716	CcSEcCtD
Mivacurium—Angiopathy—Docetaxel—stomach cancer	0.0032	0.00706	CcSEcCtD
Mivacurium—Immune system disorder—Docetaxel—stomach cancer	0.00318	0.00703	CcSEcCtD
Mivacurium—Mediastinal disorder—Docetaxel—stomach cancer	0.00317	0.00702	CcSEcCtD
Mivacurium—Flushing—Capecitabine—stomach cancer	0.00317	0.007	CcSEcCtD
Mivacurium—Cardiac disorder—Capecitabine—stomach cancer	0.00317	0.007	CcSEcCtD
Mivacurium—Arrhythmia—Docetaxel—stomach cancer	0.00315	0.00696	CcSEcCtD
Mivacurium—Angiopathy—Capecitabine—stomach cancer	0.00309	0.00684	CcSEcCtD
Mivacurium—Immune system disorder—Capecitabine—stomach cancer	0.00308	0.00681	CcSEcCtD
Mivacurium—Mediastinal disorder—Capecitabine—stomach cancer	0.00307	0.00679	CcSEcCtD
Mivacurium—Erythema—Docetaxel—stomach cancer	0.00307	0.00678	CcSEcCtD
Mivacurium—Arrhythmia—Capecitabine—stomach cancer	0.00305	0.00673	CcSEcCtD
Mivacurium—Erythema—Capecitabine—stomach cancer	0.00297	0.00656	CcSEcCtD
Mivacurium—Muscle spasms—Docetaxel—stomach cancer	0.00295	0.00652	CcSEcCtD
Mivacurium—Muscle spasms—Capecitabine—stomach cancer	0.00285	0.00631	CcSEcCtD
Mivacurium—Urticaria—Fluorouracil—stomach cancer	0.00275	0.00609	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.00259	0.00573	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.00251	0.00555	CcSEcCtD
Mivacurium—Anaphylactic shock—Docetaxel—stomach cancer	0.0025	0.00553	CcSEcCtD
Mivacurium—Tachycardia—Docetaxel—stomach cancer	0.00244	0.0054	CcSEcCtD
Mivacurium—Skin disorder—Docetaxel—stomach cancer	0.00243	0.00537	CcSEcCtD
Mivacurium—Bradycardia—Epirubicin—stomach cancer	0.00242	0.00535	CcSEcCtD
Mivacurium—Dizziness—Irinotecan—stomach cancer	0.00239	0.00529	CcSEcCtD
Mivacurium—Tachycardia—Capecitabine—stomach cancer	0.00236	0.00523	CcSEcCtD
Mivacurium—Cardiac disorder—Methotrexate—stomach cancer	0.00236	0.00521	CcSEcCtD
Mivacurium—Skin disorder—Capecitabine—stomach cancer	0.00235	0.0052	CcSEcCtD
Mivacurium—Hypotension—Docetaxel—stomach cancer	0.00234	0.00517	CcSEcCtD
Mivacurium—Angiopathy—Methotrexate—stomach cancer	0.0023	0.00509	CcSEcCtD
Mivacurium—Immune system disorder—Methotrexate—stomach cancer	0.00229	0.00507	CcSEcCtD
Mivacurium—Dizziness—Fluorouracil—stomach cancer	0.00229	0.00507	CcSEcCtD
Mivacurium—Mediastinal disorder—Methotrexate—stomach cancer	0.00229	0.00506	CcSEcCtD
Mivacurium—Rash—Irinotecan—stomach cancer	0.00228	0.00505	CcSEcCtD
Mivacurium—Dermatitis—Irinotecan—stomach cancer	0.00228	0.00504	CcSEcCtD
Mivacurium—Hypotension—Capecitabine—stomach cancer	0.00226	0.005	CcSEcCtD
Mivacurium—Bradycardia—Doxorubicin—stomach cancer	0.00224	0.00495	CcSEcCtD
Mivacurium—Erythema—Methotrexate—stomach cancer	0.00221	0.00488	CcSEcCtD
Mivacurium—Flushing—Epirubicin—stomach cancer	0.00221	0.00487	CcSEcCtD
Mivacurium—Cardiac disorder—Epirubicin—stomach cancer	0.00221	0.00487	CcSEcCtD
Mivacurium—Rash—Fluorouracil—stomach cancer	0.00219	0.00483	CcSEcCtD
Mivacurium—Dermatitis—Fluorouracil—stomach cancer	0.00218	0.00483	CcSEcCtD
Mivacurium—Angiopathy—Epirubicin—stomach cancer	0.00216	0.00476	CcSEcCtD
Mivacurium—Immune system disorder—Epirubicin—stomach cancer	0.00215	0.00474	CcSEcCtD
Mivacurium—Mediastinal disorder—Epirubicin—stomach cancer	0.00214	0.00473	CcSEcCtD
Mivacurium—Arrhythmia—Epirubicin—stomach cancer	0.00212	0.00469	CcSEcCtD
Mivacurium—Erythema—Epirubicin—stomach cancer	0.00207	0.00457	CcSEcCtD
Mivacurium—Flushing—Doxorubicin—stomach cancer	0.00204	0.00451	CcSEcCtD
Mivacurium—Cardiac disorder—Doxorubicin—stomach cancer	0.00204	0.00451	CcSEcCtD
Mivacurium—Angiopathy—Doxorubicin—stomach cancer	0.00199	0.00441	CcSEcCtD
Mivacurium—Muscle spasms—Epirubicin—stomach cancer	0.00199	0.0044	CcSEcCtD
Mivacurium—Immune system disorder—Doxorubicin—stomach cancer	0.00199	0.00439	CcSEcCtD
Mivacurium—Mediastinal disorder—Doxorubicin—stomach cancer	0.00198	0.00438	CcSEcCtD
Mivacurium—Arrhythmia—Doxorubicin—stomach cancer	0.00196	0.00434	CcSEcCtD
Mivacurium—Urticaria—Capecitabine—stomach cancer	0.00193	0.00425	CcSEcCtD
Mivacurium—Erythema—Doxorubicin—stomach cancer	0.00191	0.00423	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.00187	0.00413	CcSEcCtD
Mivacurium—Muscle spasms—Doxorubicin—stomach cancer	0.00184	0.00407	CcSEcCtD
Mivacurium—Anaphylactic shock—Methotrexate—stomach cancer	0.0018	0.00399	CcSEcCtD
Mivacurium—Skin disorder—Methotrexate—stomach cancer	0.00175	0.00387	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.00175	0.00387	CcSEcCtD
Mivacurium—Anaphylactic shock—Epirubicin—stomach cancer	0.00169	0.00373	CcSEcCtD
Mivacurium—Hypotension—Methotrexate—stomach cancer	0.00169	0.00373	CcSEcCtD
Mivacurium—Dizziness—Docetaxel—stomach cancer	0.00166	0.00366	CcSEcCtD
Mivacurium—Tachycardia—Epirubicin—stomach cancer	0.00165	0.00364	CcSEcCtD
Mivacurium—Skin disorder—Epirubicin—stomach cancer	0.00164	0.00362	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.00162	0.00358	CcSEcCtD
Mivacurium—Dizziness—Capecitabine—stomach cancer	0.0016	0.00354	CcSEcCtD
Mivacurium—Rash—Docetaxel—stomach cancer	0.00158	0.00349	CcSEcCtD
Mivacurium—Hypotension—Epirubicin—stomach cancer	0.00158	0.00349	CcSEcCtD
Mivacurium—Dermatitis—Docetaxel—stomach cancer	0.00158	0.00348	CcSEcCtD
Mivacurium—Anaphylactic shock—Doxorubicin—stomach cancer	0.00156	0.00345	CcSEcCtD
Mivacurium—Rash—Capecitabine—stomach cancer	0.00153	0.00338	CcSEcCtD
Mivacurium—Dermatitis—Capecitabine—stomach cancer	0.00153	0.00337	CcSEcCtD
Mivacurium—Tachycardia—Doxorubicin—stomach cancer	0.00152	0.00337	CcSEcCtD
Mivacurium—Skin disorder—Doxorubicin—stomach cancer	0.00152	0.00335	CcSEcCtD
Mivacurium—Hypotension—Doxorubicin—stomach cancer	0.00146	0.00323	CcSEcCtD
Mivacurium—Urticaria—Methotrexate—stomach cancer	0.00143	0.00317	CcSEcCtD
Mivacurium—Urticaria—Epirubicin—stomach cancer	0.00134	0.00296	CcSEcCtD
Mivacurium—Urticaria—Doxorubicin—stomach cancer	0.00124	0.00274	CcSEcCtD
Mivacurium—Dizziness—Methotrexate—stomach cancer	0.00119	0.00264	CcSEcCtD
Mivacurium—Rash—Methotrexate—stomach cancer	0.00114	0.00251	CcSEcCtD
Mivacurium—Dermatitis—Methotrexate—stomach cancer	0.00114	0.00251	CcSEcCtD
Mivacurium—Dizziness—Epirubicin—stomach cancer	0.00112	0.00247	CcSEcCtD
Mivacurium—Rash—Epirubicin—stomach cancer	0.00106	0.00235	CcSEcCtD
Mivacurium—Dermatitis—Epirubicin—stomach cancer	0.00106	0.00235	CcSEcCtD
Mivacurium—Dizziness—Doxorubicin—stomach cancer	0.00103	0.00228	CcSEcCtD
Mivacurium—Rash—Doxorubicin—stomach cancer	0.000985	0.00218	CcSEcCtD
Mivacurium—Dermatitis—Doxorubicin—stomach cancer	0.000984	0.00217	CcSEcCtD
Mivacurium—CHRM2—G alpha (i) signalling events—CXCL8—stomach cancer	6.59e-05	0.000876	CbGpPWpGaD
Mivacurium—CHRM2—Regulation of Actin Cytoskeleton—KRAS—stomach cancer	6.55e-05	0.000871	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—AGTR2—stomach cancer	6.46e-05	0.000859	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—WWOX—stomach cancer	6.42e-05	0.000854	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—AGTR2—stomach cancer	6.4e-05	0.000851	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—F2R—stomach cancer	6.39e-05	0.00085	CbGpPWpGaD
Mivacurium—CHRM2—SIDS Susceptibility Pathways—TNF—stomach cancer	6.36e-05	0.000846	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—PDHA1—stomach cancer	6.36e-05	0.000846	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—ECHS1—stomach cancer	6.36e-05	0.000846	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	6.36e-05	0.000846	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—WWOX—stomach cancer	6.36e-05	0.000845	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	6.34e-05	0.000844	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—F2R—stomach cancer	6.33e-05	0.000841	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—ALOX5—stomach cancer	6.27e-05	0.000834	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—HTR1A—stomach cancer	6.22e-05	0.000827	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—DPYD—stomach cancer	6.17e-05	0.00082	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—HTR1A—stomach cancer	6.16e-05	0.000819	CbGpPWpGaD
Mivacurium—CHRM3—Regulation of Actin Cytoskeleton—PIK3CA—stomach cancer	6.08e-05	0.000808	CbGpPWpGaD
Mivacurium—CHRM2—Regulation of Actin Cytoskeleton—PIK3CA—stomach cancer	6.02e-05	0.0008	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—ANXA1—stomach cancer	6.01e-05	0.000799	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—FADS1—stomach cancer	5.98e-05	0.000795	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—TYMP—stomach cancer	5.98e-05	0.000795	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—WIF1—stomach cancer	5.97e-05	0.000794	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—HRH4—stomach cancer	5.97e-05	0.000794	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—ANXA1—stomach cancer	5.95e-05	0.000791	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—HRH4—stomach cancer	5.91e-05	0.000786	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—WIF1—stomach cancer	5.91e-05	0.000786	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—AGTR2—stomach cancer	5.87e-05	0.00078	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—ADRB1—stomach cancer	5.82e-05	0.000774	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—AGTR2—stomach cancer	5.81e-05	0.000773	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—F2R—stomach cancer	5.8e-05	0.000772	CbGpPWpGaD
Mivacurium—BCHE—Transmission across Chemical Synapses—HRAS—stomach cancer	5.78e-05	0.000768	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—ADRB1—stomach cancer	5.76e-05	0.000766	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—F2R—stomach cancer	5.74e-05	0.000764	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—HTR1A—stomach cancer	5.65e-05	0.000751	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—SREBF2—stomach cancer	5.6e-05	0.000745	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—HTR1A—stomach cancer	5.59e-05	0.000744	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	5.59e-05	0.000743	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—RORA—stomach cancer	5.53e-05	0.000736	CbGpPWpGaD
Mivacurium—BCHE—Neuronal System—MAPK1—stomach cancer	5.51e-05	0.000733	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PRKAB1—stomach cancer	5.51e-05	0.000732	CbGpPWpGaD
Mivacurium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—stomach cancer	5.49e-05	0.00073	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—ANXA1—stomach cancer	5.45e-05	0.000725	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—GSTT1—stomach cancer	5.45e-05	0.000725	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PRKAB1—stomach cancer	5.45e-05	0.000725	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—ANXA1—stomach cancer	5.4e-05	0.000718	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—CYP2A6—stomach cancer	5.39e-05	0.000717	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—KISS1—stomach cancer	5.32e-05	0.000707	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—RNF43—stomach cancer	5.32e-05	0.000707	CbGpPWpGaD
Mivacurium—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	5.29e-05	0.000703	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—ADRB1—stomach cancer	5.28e-05	0.000703	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—RNF43—stomach cancer	5.27e-05	0.0007	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—KISS1—stomach cancer	5.27e-05	0.0007	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—AKR1C3—stomach cancer	5.24e-05	0.000697	CbGpPWpGaD
Mivacurium—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	5.24e-05	0.000697	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—ADRB1—stomach cancer	5.23e-05	0.000696	CbGpPWpGaD
Mivacurium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—stomach cancer	5.22e-05	0.000695	CbGpPWpGaD
Mivacurium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—stomach cancer	5.22e-05	0.000694	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—ALDOB—stomach cancer	5.18e-05	0.00069	CbGpPWpGaD
Mivacurium—CHRM2—SIDS Susceptibility Pathways—IL6—stomach cancer	5.14e-05	0.000683	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—ENO1—stomach cancer	5.11e-05	0.00068	CbGpPWpGaD
Mivacurium—CHRM3—G alpha (q) signalling events—PIK3CA—stomach cancer	5.07e-05	0.000674	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of lipids and lipoproteins—ALB—stomach cancer	5.03e-05	0.000668	CbGpPWpGaD
Mivacurium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—stomach cancer	4.93e-05	0.000656	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—ALOX5—stomach cancer	4.82e-05	0.000641	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—DPYD—stomach cancer	4.74e-05	0.000631	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—FST—stomach cancer	4.74e-05	0.00063	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—ADRB2—stomach cancer	4.71e-05	0.000627	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—FST—stomach cancer	4.69e-05	0.000624	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—ADRB2—stomach cancer	4.67e-05	0.000621	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—HBEGF—stomach cancer	4.64e-05	0.000617	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—HBEGF—stomach cancer	4.59e-05	0.000611	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—RGS2—stomach cancer	4.57e-05	0.000608	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—GAST—stomach cancer	4.57e-05	0.000608	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—CD44—stomach cancer	4.53e-05	0.000603	CbGpPWpGaD
Mivacurium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—stomach cancer	4.53e-05	0.000603	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—GAST—stomach cancer	4.53e-05	0.000602	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—RGS2—stomach cancer	4.53e-05	0.000602	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of proteins—MMP2—stomach cancer	4.43e-05	0.00059	CbGpPWpGaD
Mivacurium—BCHE—Neuronal System—HRAS—stomach cancer	4.43e-05	0.000589	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	4.4e-05	0.000585	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—FGG—stomach cancer	4.34e-05	0.000577	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—FGG—stomach cancer	4.29e-05	0.000571	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—ADRB2—stomach cancer	4.28e-05	0.000569	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—ADRB2—stomach cancer	4.24e-05	0.000564	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—PPP2R1A—stomach cancer	4.19e-05	0.000558	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—GSTT1—stomach cancer	4.19e-05	0.000558	CbGpPWpGaD
Mivacurium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—stomach cancer	4.19e-05	0.000558	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PRKAA1—stomach cancer	4.17e-05	0.000555	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—PPP2R1A—stomach cancer	4.15e-05	0.000552	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—CYP2A6—stomach cancer	4.14e-05	0.000551	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PRKAA1—stomach cancer	4.13e-05	0.00055	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—AKR1C3—stomach cancer	4.03e-05	0.000536	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—RBP4—stomach cancer	4.03e-05	0.000536	CbGpPWpGaD
Mivacurium—CHRM3—GPCR ligand binding—CXCL8—stomach cancer	4.03e-05	0.000536	CbGpPWpGaD
Mivacurium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—stomach cancer	4.01e-05	0.000534	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—RBP4—stomach cancer	3.99e-05	0.000531	CbGpPWpGaD
Mivacurium—CHRM2—GPCR ligand binding—CXCL8—stomach cancer	3.99e-05	0.000531	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—ENO1—stomach cancer	3.93e-05	0.000523	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—PPP2R1A—stomach cancer	3.85e-05	0.000512	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—GSTP1—stomach cancer	3.78e-05	0.000503	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—HMOX1—stomach cancer	3.73e-05	0.000496	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of proteins—CXCL8—stomach cancer	3.68e-05	0.00049	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—TYMS—stomach cancer	3.51e-05	0.000467	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—CD44—stomach cancer	3.48e-05	0.000463	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—GSTM1—stomach cancer	3.47e-05	0.000462	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—HSPB1—stomach cancer	3.47e-05	0.000461	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—AGTR2—stomach cancer	3.47e-05	0.000461	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—AGTR2—stomach cancer	3.43e-05	0.000456	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—HSPB1—stomach cancer	3.43e-05	0.000456	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—BMP2—stomach cancer	3.43e-05	0.000456	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—F2R—stomach cancer	3.43e-05	0.000456	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—BMP2—stomach cancer	3.39e-05	0.000451	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—F2R—stomach cancer	3.39e-05	0.000451	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—AKR1C3—stomach cancer	3.37e-05	0.000448	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—AKR1C3—stomach cancer	3.34e-05	0.000444	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—HTR1A—stomach cancer	3.34e-05	0.000444	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—HTR1A—stomach cancer	3.3e-05	0.000439	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—ERCC2—stomach cancer	3.27e-05	0.000434	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—PRKCB—stomach cancer	3.23e-05	0.00043	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—ANXA1—stomach cancer	3.22e-05	0.000429	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—PRKCB—stomach cancer	3.2e-05	0.000425	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—ANXA1—stomach cancer	3.19e-05	0.000424	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—ADRB1—stomach cancer	3.12e-05	0.000415	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—ADRB1—stomach cancer	3.09e-05	0.000411	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—MTHFR—stomach cancer	3.07e-05	0.000408	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—RPS6—stomach cancer	2.98e-05	0.000397	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—PPP2R1A—stomach cancer	2.96e-05	0.000394	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—RPS6—stomach cancer	2.95e-05	0.000393	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—PRKCB—stomach cancer	2.93e-05	0.00039	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—IL6ST—stomach cancer	2.92e-05	0.000389	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—GSTP1—stomach cancer	2.91e-05	0.000387	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—PRKCB—stomach cancer	2.9e-05	0.000386	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—IL6ST—stomach cancer	2.89e-05	0.000385	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—HMOX1—stomach cancer	2.87e-05	0.000381	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—CAV1—stomach cancer	2.83e-05	0.000377	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—APOA1—stomach cancer	2.83e-05	0.000376	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—HBEGF—stomach cancer	2.74e-05	0.000364	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—HBEGF—stomach cancer	2.71e-05	0.000361	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	2.71e-05	0.00036	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—TYMS—stomach cancer	2.7e-05	0.000359	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—GSTM1—stomach cancer	2.67e-05	0.000355	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—IL6R—stomach cancer	2.61e-05	0.000347	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—RHOA—stomach cancer	2.59e-05	0.000345	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—IL6R—stomach cancer	2.58e-05	0.000343	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—RHOA—stomach cancer	2.57e-05	0.000342	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—ADRB2—stomach cancer	2.53e-05	0.000336	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—ERCC2—stomach cancer	2.51e-05	0.000334	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—ADRB2—stomach cancer	2.5e-05	0.000333	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—PPARG—stomach cancer	2.49e-05	0.000331	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PPP2R1A—stomach cancer	2.48e-05	0.00033	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PPP2R1A—stomach cancer	2.45e-05	0.000326	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—MTHFR—stomach cancer	2.36e-05	0.000314	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—RHOA—stomach cancer	2.35e-05	0.000313	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—RHOA—stomach cancer	2.33e-05	0.00031	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—SMAD4—stomach cancer	2.3e-05	0.000306	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—SMAD4—stomach cancer	2.28e-05	0.000303	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—CXCL8—stomach cancer	2.28e-05	0.000303	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—CXCL8—stomach cancer	2.25e-05	0.0003	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—ALB—stomach cancer	2.24e-05	0.000298	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—FYN—stomach cancer	2.18e-05	0.000291	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—CAV1—stomach cancer	2.18e-05	0.00029	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—APOA1—stomach cancer	2.17e-05	0.000289	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—FYN—stomach cancer	2.16e-05	0.000288	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—NOS3—stomach cancer	2.14e-05	0.000285	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—CXCL8—stomach cancer	2.07e-05	0.000275	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—FGFR2—stomach cancer	2.05e-05	0.000273	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—CXCL8—stomach cancer	2.05e-05	0.000272	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—FGFR2—stomach cancer	2.03e-05	0.00027	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—PTGS2—stomach cancer	1.96e-05	0.00026	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—PPARG—stomach cancer	1.91e-05	0.000255	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—IRS2—stomach cancer	1.88e-05	0.00025	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—IRS2—stomach cancer	1.86e-05	0.000247	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CAV1—stomach cancer	1.82e-05	0.000242	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—APOA1—stomach cancer	1.82e-05	0.000242	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CAV1—stomach cancer	1.8e-05	0.00024	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—APOA1—stomach cancer	1.8e-05	0.000239	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PRKCB—stomach cancer	1.73e-05	0.00023	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—IL6ST—stomach cancer	1.73e-05	0.00023	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—ALB—stomach cancer	1.72e-05	0.000229	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PRKCB—stomach cancer	1.72e-05	0.000228	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—IL6ST—stomach cancer	1.71e-05	0.000227	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—APC—stomach cancer	1.66e-05	0.000221	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—NOS3—stomach cancer	1.65e-05	0.000219	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—APC—stomach cancer	1.64e-05	0.000218	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—MAPK3—stomach cancer	1.59e-05	0.000211	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—MAPK3—stomach cancer	1.57e-05	0.000209	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—IL6R—stomach cancer	1.54e-05	0.000205	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—IL6R—stomach cancer	1.52e-05	0.000203	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—MAPK1—stomach cancer	1.51e-05	0.000201	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—EGFR—stomach cancer	1.51e-05	0.000201	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—PTGS2—stomach cancer	1.51e-05	0.0002	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—MAPK1—stomach cancer	1.5e-05	0.000199	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—EGFR—stomach cancer	1.5e-05	0.000199	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—PIK3CA—stomach cancer	1.44e-05	0.000192	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—SERPINE1—stomach cancer	1.44e-05	0.000192	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—PIK3CA—stomach cancer	1.43e-05	0.00019	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—SERPINE1—stomach cancer	1.43e-05	0.00019	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—KRAS—stomach cancer	1.43e-05	0.00019	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—KRAS—stomach cancer	1.41e-05	0.000188	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—RHOA—stomach cancer	1.39e-05	0.000185	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—RHOA—stomach cancer	1.38e-05	0.000183	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—NOS3—stomach cancer	1.38e-05	0.000183	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—NOS3—stomach cancer	1.36e-05	0.000181	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—PIK3CA—stomach cancer	1.31e-05	0.000174	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—PIK3CA—stomach cancer	1.3e-05	0.000173	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—ERBB2—stomach cancer	1.29e-05	0.000171	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—ERBB2—stomach cancer	1.28e-05	0.00017	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CXCL8—stomach cancer	1.22e-05	0.000162	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—HRAS—stomach cancer	1.21e-05	0.000161	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CXCL8—stomach cancer	1.21e-05	0.000161	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—PIK3CA—stomach cancer	1.2e-05	0.00016	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—HRAS—stomach cancer	1.2e-05	0.00016	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CDKN1B—stomach cancer	1.19e-05	0.000159	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CDKN1B—stomach cancer	1.18e-05	0.000157	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—IL6—stomach cancer	1.16e-05	0.000154	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—IL6—stomach cancer	1.15e-05	0.000153	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CCND1—stomach cancer	1.14e-05	0.000151	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—JUN—stomach cancer	1.14e-05	0.000151	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CCND1—stomach cancer	1.13e-05	0.00015	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—JUN—stomach cancer	1.12e-05	0.00015	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—MMP9—stomach cancer	1.1e-05	0.000147	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CDKN1A—stomach cancer	1.1e-05	0.000146	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—MMP9—stomach cancer	1.09e-05	0.000145	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CDKN1A—stomach cancer	1.09e-05	0.000145	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—MAPK8—stomach cancer	1.07e-05	0.000143	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—MAPK8—stomach cancer	1.06e-05	0.000141	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—VEGFA—stomach cancer	9.92e-06	0.000132	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—VEGFA—stomach cancer	9.82e-06	0.000131	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—STAT3—stomach cancer	9.82e-06	0.000131	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—STAT3—stomach cancer	9.72e-06	0.000129	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—MAPK3—stomach cancer	9.38e-06	0.000125	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—MAPK3—stomach cancer	9.29e-06	0.000124	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—PIK3CA—stomach cancer	9.26e-06	0.000123	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—MYC—stomach cancer	9.12e-06	0.000121	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—MYC—stomach cancer	9.04e-06	0.00012	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—MAPK1—stomach cancer	8.93e-06	0.000119	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—EGFR—stomach cancer	8.93e-06	0.000119	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—MAPK1—stomach cancer	8.84e-06	0.000118	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—EGFR—stomach cancer	8.84e-06	0.000118	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—KRAS—stomach cancer	8.43e-06	0.000112	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—KRAS—stomach cancer	8.35e-06	0.000111	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PIK3CA—stomach cancer	7.75e-06	0.000103	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PIK3CA—stomach cancer	7.67e-06	0.000102	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—TP53—stomach cancer	7.49e-06	9.97e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—TP53—stomach cancer	7.42e-06	9.87e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—HRAS—stomach cancer	7.17e-06	9.53e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—HRAS—stomach cancer	7.1e-06	9.44e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—IL6—stomach cancer	6.86e-06	9.12e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—IL6—stomach cancer	6.79e-06	9.03e-05	CbGpPWpGaD
